Actively Recruiting

All Genders
ID06447168

Prospective Non-interventional Multicentre Study to Assess Effectiveness, Safety, and Tolerability of Elafibranor 80 mg/Day in Primary Biliary Cholangitis Patients in Real-World Treatment

Led by Ipsen · Updated on 2026-05-28

424

Participants Needed

68

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are observing the real-world use of the drug elafibranor in people with Primary Biliary Cholangitis (PBC), a rare progressive liver disease where bile ducts are damaged. This damage can cause liver scarring and symptoms like itching and fatigue. The study aims to collect information on how effective, safe, and tolerable elafibranor is for PBC patients receiving ongoing treatment. Each participant will be part of the study for about 5 years. Participants will continue their treatment with elafibranor as prescribed by their doctors while researchers gather data without altering care. The study monitors participants over a 60-month period, collecting information during routine physician follow-up visits. There is no placebo or comparison group since this is an observational study focusing on real-world use of elafibranor. During the study, researchers will track treatment response at 6 months and follow liver function tests, symptom changes like itching and fatigue, quality of life, liver stiffness, and safety measures up to 5 years. They will also assess participant satisfaction and adherence to treatment. Data is collected during regular medical visits, making participation flexible and integrated with usual care.

CONDITIONS

Brief Title

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant has provided written informed consent and agrees to comply with the study protocol.
  • Participant has a diagnosis of Primary Biliary Cholangitis (PBC).
  • Participant is starting or currently receiving treatment with commercially available elafibranor.
  • If applicable, caregiver consents to complete caregiver questionnaires before data collection.
Not Eligible

You will not qualify if you...

  • Participant is currently enrolled or plans to enroll in another investigational drug or medical device study.
  • Participant has known hypersensitivity to elafibranor or any of its ingredients.
  • Participant has mental instability or incompetence that may affect informed consent validity or study compliance.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 60 months

Participants who are receiving ongoing treatment with elafibranor are observed during routine physician follow-up visits to assess effectiveness, safety, and tolerability.

Routine physician follow-up visits up to 60 months

Trial Site Locations

Total: 68 locations

1

Southern California Research Center

Coronado, California, United States, 92118

Actively Recruiting

2

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Not Yet Recruiting

3

University of California Davis Medical Center

Sacramento, California, United States, 95817

Actively Recruiting

4

South Denver Gastroenterology,P.C.

Englewood, Colorado, United States, 80113

Actively Recruiting

5

Yale University School of Medicine

New Haven, Connecticut, United States, 06510

Actively Recruiting

6

Schiff Center for Liver Diseases - University of Miami

Miami, Florida, United States, 33136

Actively Recruiting

7

Beth Israel Deaconess Medical Center, Liver Research Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

8

Virtua Center for Liver Disease - Cherry Hill

Cherry Hill, New Jersey, United States, 08034

Actively Recruiting

9

Northwell Health Inc, Center for Liver Disease and Transplantation

Manhasset, New York, United States, 11030

Actively Recruiting

10

UNC Hospitals, The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

11

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

12

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States, 29425

Actively Recruiting

13

Liver Center of Texas

Dallas, Texas, United States, 75234

Actively Recruiting

14

Baylor College of Medicine - Advanced Liver Therapies

Houston, Texas, United States, 77030

Actively Recruiting

15

Gastro health & Nutrition

Katy, Texas, United States, 77494

Withdrawn

16

Texas Digestive Specialists

McAllen, Texas, United States, 78504

Actively Recruiting

17

Intermountain Medical Center

Murray, Utah, United States, 84107

Actively Recruiting

18

Bon Secours Richmond Community Hospital LLC. d/b/a Bon Secours Liver Institute of Richmond

Richmond, Virginia, United States, 23226

Actively Recruiting

19

Virginia Commonwealth University Medical Center - West Hospital

Richmond, Virginia, United States, 23298

Actively Recruiting

20

Velocity Clinical Research

Seattle, Washington, United States, 98105

Actively Recruiting

21

St Vincent's Hospital

Fitzroy, Australia, 3065

Not Yet Recruiting

22

Medizinische Universitaetsklinik Graz

Graz, Austria

Actively Recruiting

23

Medical University Innsbruck

Innsbruck, Austria

Actively Recruiting

24

Ordensklinikum Linz GmbH Barmherzige Schwestern

Linz, Austria

Actively Recruiting

25

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)

Montreal, Quebec, Canada, H2X 0A9

Not Yet Recruiting

26

University of Calgary

Calgary, Canada

Actively Recruiting

27

London Health Sciences Centre (LHSC) - University Hospital

London, Canada

Actively Recruiting

28

The Ottawa Hospital - General Campus

Ottawa, Canada

Actively Recruiting

29

(G.I.R.I) GI Research Institute Foundation

Vancouver, Canada

Actively Recruiting

30

Charite Universitatsmedizin Berlin

Berlin, Germany

Actively Recruiting

31

DRK Kliniken Berlin Mitte

Berlin, Germany

Actively Recruiting

32

Klinikum der Johann Wolfgang Goethe-Universitaet

Frankfurt, Germany

Not Yet Recruiting

33

Studiengesellschaft BSF

Halle, Germany

Actively Recruiting

34

Gastroenterologsiche Studiengesellschaft Herne

Herne, Germany

Actively Recruiting

35

Universitaet des Saarlandes

Homburg, Germany

Actively Recruiting

36

Universitaetsklinikum Leipzig

Leipzig, Germany

Actively Recruiting

37

Hospital of the Merciful Brothers Trier

Trier, Germany

Withdrawn

38

General Hospital of Athens Laiko

Athens, Greece

Actively Recruiting

39

University Hospital of Heraklion

Heraklion, Greece

Actively Recruiting

40

University General Hospital of Larissa

Larissa, Greece

Actively Recruiting

41

University General Hospital of Patras

Pátrai, Greece

Actively Recruiting

42

Ippokratio General Hospital of Thessaloniki

Thessaloniki, Greece

Actively Recruiting

43

ASST-Ospedale Papa Giovanni XXIII

Bergamo, Italy

Not Yet Recruiting

44

Ospedale Garibaldi Nesima

Catania, Italy

Actively Recruiting

45

Universita Degli Studi Di Firenze - Azienda Ospedaliero-Universitaria Careggi (AOUC)

Florence, Italy

Actively Recruiting

46

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy

Actively Recruiting

47

Ospedale Maggiore Della Carita

Novara, Italy

Actively Recruiting

48

A. Gemelli University Hospital, Catholic University of the Sacred Heart

Roma, Italy

Not Yet Recruiting

49

Fondazione Policlinico Universitario Campus Bio-Medico

Roma, Italy

Actively Recruiting

50

Hospital de Torrecardenas

Almería, Spain

Actively Recruiting

51

Hospital Clinic de Barcelona (Hospital Clinic i Provincial)

Barcelona, Spain

Actively Recruiting

52

Hospital Universitario Vall d'Hebron

Barcelona, Spain

Actively Recruiting

53

Hospital General Universitario Gregorio Maranon (HGUGM)

Madrid, Spain, 28007

Actively Recruiting

54

Complexo Hospitalario Universitario de Pontevedra

Pontevedra, Spain

Actively Recruiting

55

Instituto De Investigacion Marques De Valdecilla (IDIVAL)

Santander, Spain

Actively Recruiting

56

Clemenceau Medical Center Hospital

Dubai, United Arab Emirates

Not Yet Recruiting

57

Mediclinic Airport Road Hospital

Dubai, United Arab Emirates

Actively Recruiting

58

Rashid Hospital

Dubai, United Arab Emirates

Not Yet Recruiting

59

Sheikh Shakhbout Medical City

Dubai, United Arab Emirates

Actively Recruiting

60

Aberdeen Royal Infirmary NHS Grampian Grampian Health Board

Aberdeen, United Kingdom

Actively Recruiting

61

Belfast Health and Social Care Trust - Royal Victoria Hospital

Belfast, United Kingdom

Actively Recruiting

62

Queen Elizabeth Hospital Birmingham - University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

Actively Recruiting

63

Bradford Royal Infirmary - Bradford Teaching Hospitals NHS Foundation

Bradford, United Kingdom

Actively Recruiting

64

Hull Royal Infirmary - Hull University Teaching Hospitals NHS Trust

Hull, United Kingdom

Actively Recruiting

65

King's College Hospital NHS Foundation Trust

London, United Kingdom

Actively Recruiting

66

The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital

Newcastle, United Kingdom

Actively Recruiting

67

Queen's Medical Centre - Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Not Yet Recruiting

68

John Radcliffe Hospital - Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom

Actively Recruiting

Loading map...

Research Team

I

Ipsen Clinical Study Enquiries

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Randomized, Double-Blind, Placebo-Controlled Study to Eval...

Primary Biliary Cholangitis

Actively Recruiting

41 locations

A Randomized, Double-Blind, Placebo-Controlled Study to Eval...

Primary Biliary Cholangitis

Actively Recruiting

130 locations

Characterisation of Patients With Primary Biliary Cholangiti...

Primary Biliary Cholangitis

Actively Recruiting

11 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here